Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Mar;21(3):131-132.
doi: 10.1038/s41577-020-00493-9.

Endemic SARS-CoV-2 will maintain post-pandemic immunity

Marc Veldhoen  1 , J Pedro Simas  2   3
Affiliations

Endemic SARS-CoV-2 will maintain post-pandemic immunity

Marc Veldhoen et al. Nat Rev Immunol. 2021 Mar.

Abstract

COVID-19 vaccinations have started. They will stop the pandemic. Citing recent data that are in line with immunological knowledge and predictions, combined with insights of common cold coronaviruses, we here set out the case that the maintenance of population immunity will not depend on continued vaccinations but on the endemic presence of SARS-CoV-2.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

References

    1. Figueiredo-Campos P, et al. Seroprevalence of anti-SARS-CoV-2 antibodies in COVID-19 patients and healthy volunteers up to 6 months post disease onset. Eur. J. Immunol. 2020;50:2025–2040. doi: 10.1002/eji.202048970. - DOI - PMC - PubMed
    1. Iyer AS, et al. Persistence and decay of human antibody responses to the receptor binding domain of SARS-CoV-2 spike protein in COVID-19 patients. Sci. Immunol. 2020;5:eabe0367. doi: 10.1126/sciimmunol.abe0367. - DOI - PMC - PubMed
    1. Wajnberg A, et al. Robust neutralizing antibodies to SARS-CoV-2 infection persist for months. Science. 2020;370:1227–1230. doi: 10.1126/science.abd7728. - DOI - PMC - PubMed
    1. Ripperger TJ, et al. Orthogonal SARS-CoV-2 serological assays enable surveillance of low prevalence communities and reveal durable humoral immunity. Immunity. 2020;53:925–933. doi: 10.1016/j.immuni.2020.10.004. - DOI - PMC - PubMed
    1. Stadlbauer D, et al. Repeated cross-sectional sero-monitoring of SARS-CoV-2 in New York City. Nature. 2020 doi: 10.1038/s41586-020-2912-6. - DOI - PubMed